Sierra Oncology Announces Abstracts Accepted for American Society of Clinical Oncology Annual Meeting
Sierra Oncology Announces Abstracts Accepted for American Society of Clinical Oncology Annual Meeting News provided by Share this article independence and overall survival to be presented— SAN MATEO, Calif., May 19, 2021 May 19, 2021 - Sierra Oncology, Inc. (SRRA), a late-stage biopharmaceutical company on a quest to deliver targeted therapies that treat rare forms of cancer, today announced three abstracts have been accepted into the program for the 2021 Annual Meeting of the American Society of Clinical Oncology (ASCO) being held virtually from June 4-8, 2021. Association of Transfus...